HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum
The relationships of cell cholesterol efflux to HDL phospholipid (PL) content and composition in human serum were analyzed in two groups of subjects selected on the basis of their HDL cholesterol (HDL-C) levelsa norm-HDL group (1.10 mmol/L < HDL-C < 1.50 mmol/L) and a high-HDL group (HDL-C >...
Gespeichert in:
Veröffentlicht in: | Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 1997-11, Vol.17 (11), p.2685-2691 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2691 |
---|---|
container_issue | 11 |
container_start_page | 2685 |
container_title | Arteriosclerosis, thrombosis, and vascular biology |
container_volume | 17 |
creator | Fournier, Natalie Paul, Jean-Louis Atger, Veronique Cogny, Anne Soni, Theophile de la Llera-Moya, Margarita Rothblat, George Moatti, Nicole |
description | The relationships of cell cholesterol efflux to HDL phospholipid (PL) content and composition in human serum were analyzed in two groups of subjects selected on the basis of their HDL cholesterol (HDL-C) levelsa norm-HDL group (1.10 mmol/L < HDL-C < 1.50 mmol/L) and a high-HDL group (HDL-C > 1.75 mmol/L). In the high-HDL group, the relative fractional efflux was significantly higher than in the norm-HDL group, and in both groups, fractional efflux was correlated with a number of lipoprotein parameters, the best correlation and the only one that remained significant after multivariate analysis being with HDL phospholipid (HDL-PL). Analysis of the HDL-PL subclasses revealed that HDL in the high-HDL sera was enriched with phosphatidylethanolamine (HDL-PE) and relatively deficient in sphingomyelin (HDL-SM) compared with norm-HDL sera. Moreover, the fractional efflux values in the high-HDL group were negatively correlated with the proportion of HDL-PE (r = -.64, P < .0001) and positively correlated with the proportion of HDL-SM (r = .43, P < .01). Thus, this study provides evidence that HDL-PL concentration can he used to predict the capacity of serum to accept cellular cholesterol. Among the differences described between norm-HDL and high-HDL sera, the variability in PE to SM ratio might reflect changes in serum cholesterol acceptors that modulate the first step of reverse cholesterol transport. (Arterioscler Thromb Vasc Biol. 1997;17:2685-2691.) |
doi_str_mv | 10.1161/01.atv.17.11.2685 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79487087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>25294228</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5419-8337ca133877b5a5d6b18ed84fe3499e571de3ce230a4760031bf21295ddf2ae3</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhiMEKqXwAzggWQhxy-LxRxwfV2mXRVoEEoWr5U0c1otjp3ZC6ZVfjqNd9cBp5p15ZjSatyheA14BVPABw0pPv1cgslyRquZPikvghJWsotXTnGMhS14x8rx4kdIRY8wIwRfFhWRYEkYvi7_b6x36eghpPARnR9uhJvjJ-Alpv-TDGJKdbPBIJ6TRZ30MEW10O-VwbSYTB-ut_4maPG5S1sGhm7538x_U6FG3dnpAmxgGtJn5eosa41xCU0DbedAefTNxHl4Wz3rtknl1jlfF983NbbMtd18-fmrWu7LlDGRZUypaDZTWQuy55l21h9p0NesNZVIaLqAztDWEYs1EhTGFfU-ASN51PdGGXhXvT3vHGO7mfKwabGrzQdqbMCclJKsFrkUG3_4HHsMcfb5NkfzAuqaYZghOUBtDStH0aox20PFBAVaLOQqDWt_-UCCyVIs5eebNefG8H0z3OHF2I_ffnfs6tdr1UfvWpkeMAK6wgIyxE3YfXP54-uXmexPVwWg3HdRiMq0wL0FKAZBluZQk_QerU6YU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204288303</pqid></control><display><type>article</type><title>HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Fournier, Natalie ; Paul, Jean-Louis ; Atger, Veronique ; Cogny, Anne ; Soni, Theophile ; de la Llera-Moya, Margarita ; Rothblat, George ; Moatti, Nicole</creator><creatorcontrib>Fournier, Natalie ; Paul, Jean-Louis ; Atger, Veronique ; Cogny, Anne ; Soni, Theophile ; de la Llera-Moya, Margarita ; Rothblat, George ; Moatti, Nicole</creatorcontrib><description>The relationships of cell cholesterol efflux to HDL phospholipid (PL) content and composition in human serum were analyzed in two groups of subjects selected on the basis of their HDL cholesterol (HDL-C) levelsa norm-HDL group (1.10 mmol/L < HDL-C < 1.50 mmol/L) and a high-HDL group (HDL-C > 1.75 mmol/L). In the high-HDL group, the relative fractional efflux was significantly higher than in the norm-HDL group, and in both groups, fractional efflux was correlated with a number of lipoprotein parameters, the best correlation and the only one that remained significant after multivariate analysis being with HDL phospholipid (HDL-PL). Analysis of the HDL-PL subclasses revealed that HDL in the high-HDL sera was enriched with phosphatidylethanolamine (HDL-PE) and relatively deficient in sphingomyelin (HDL-SM) compared with norm-HDL sera. Moreover, the fractional efflux values in the high-HDL group were negatively correlated with the proportion of HDL-PE (r = -.64, P < .0001) and positively correlated with the proportion of HDL-SM (r = .43, P < .01). Thus, this study provides evidence that HDL-PL concentration can he used to predict the capacity of serum to accept cellular cholesterol. Among the differences described between norm-HDL and high-HDL sera, the variability in PE to SM ratio might reflect changes in serum cholesterol acceptors that modulate the first step of reverse cholesterol transport. (Arterioscler Thromb Vasc Biol. 1997;17:2685-2691.)</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/01.atv.17.11.2685</identifier><identifier>PMID: 9409243</identifier><identifier>CODEN: ATVBFA</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Animals ; Apolipoproteins - blood ; Biological and medical sciences ; Cholesterol - metabolism ; Cholesterol, HDL - analysis ; Disorders of blood lipids. Hyperlipoproteinemia ; Humans ; Hypercholesterolemia - blood ; Lipoproteins, HDL - blood ; Liver - metabolism ; Liver Neoplasms, Experimental - metabolism ; Liver Neoplasms, Experimental - pathology ; Male ; Medical sciences ; Metabolic diseases ; Phosphatidylethanolamines - blood ; Phospholipids - blood ; Rats ; Sphingomyelins - blood ; Tumor Cells, Cultured</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 1997-11, Vol.17 (11), p.2685-2691</ispartof><rights>1997 American Heart Association, Inc.</rights><rights>1998 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Nov 1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5419-8337ca133877b5a5d6b18ed84fe3499e571de3ce230a4760031bf21295ddf2ae3</citedby><cites>FETCH-LOGICAL-c5419-8337ca133877b5a5d6b18ed84fe3499e571de3ce230a4760031bf21295ddf2ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2106071$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9409243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fournier, Natalie</creatorcontrib><creatorcontrib>Paul, Jean-Louis</creatorcontrib><creatorcontrib>Atger, Veronique</creatorcontrib><creatorcontrib>Cogny, Anne</creatorcontrib><creatorcontrib>Soni, Theophile</creatorcontrib><creatorcontrib>de la Llera-Moya, Margarita</creatorcontrib><creatorcontrib>Rothblat, George</creatorcontrib><creatorcontrib>Moatti, Nicole</creatorcontrib><title>HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>The relationships of cell cholesterol efflux to HDL phospholipid (PL) content and composition in human serum were analyzed in two groups of subjects selected on the basis of their HDL cholesterol (HDL-C) levelsa norm-HDL group (1.10 mmol/L < HDL-C < 1.50 mmol/L) and a high-HDL group (HDL-C > 1.75 mmol/L). In the high-HDL group, the relative fractional efflux was significantly higher than in the norm-HDL group, and in both groups, fractional efflux was correlated with a number of lipoprotein parameters, the best correlation and the only one that remained significant after multivariate analysis being with HDL phospholipid (HDL-PL). Analysis of the HDL-PL subclasses revealed that HDL in the high-HDL sera was enriched with phosphatidylethanolamine (HDL-PE) and relatively deficient in sphingomyelin (HDL-SM) compared with norm-HDL sera. Moreover, the fractional efflux values in the high-HDL group were negatively correlated with the proportion of HDL-PE (r = -.64, P < .0001) and positively correlated with the proportion of HDL-SM (r = .43, P < .01). Thus, this study provides evidence that HDL-PL concentration can he used to predict the capacity of serum to accept cellular cholesterol. Among the differences described between norm-HDL and high-HDL sera, the variability in PE to SM ratio might reflect changes in serum cholesterol acceptors that modulate the first step of reverse cholesterol transport. (Arterioscler Thromb Vasc Biol. 1997;17:2685-2691.)</description><subject>Animals</subject><subject>Apolipoproteins - blood</subject><subject>Biological and medical sciences</subject><subject>Cholesterol - metabolism</subject><subject>Cholesterol, HDL - analysis</subject><subject>Disorders of blood lipids. Hyperlipoproteinemia</subject><subject>Humans</subject><subject>Hypercholesterolemia - blood</subject><subject>Lipoproteins, HDL - blood</subject><subject>Liver - metabolism</subject><subject>Liver Neoplasms, Experimental - metabolism</subject><subject>Liver Neoplasms, Experimental - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Phosphatidylethanolamines - blood</subject><subject>Phospholipids - blood</subject><subject>Rats</subject><subject>Sphingomyelins - blood</subject><subject>Tumor Cells, Cultured</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1v1DAQhiMEKqXwAzggWQhxy-LxRxwfV2mXRVoEEoWr5U0c1otjp3ZC6ZVfjqNd9cBp5p15ZjSatyheA14BVPABw0pPv1cgslyRquZPikvghJWsotXTnGMhS14x8rx4kdIRY8wIwRfFhWRYEkYvi7_b6x36eghpPARnR9uhJvjJ-Alpv-TDGJKdbPBIJ6TRZ30MEW10O-VwbSYTB-ut_4maPG5S1sGhm7538x_U6FG3dnpAmxgGtJn5eosa41xCU0DbedAefTNxHl4Wz3rtknl1jlfF983NbbMtd18-fmrWu7LlDGRZUypaDZTWQuy55l21h9p0NesNZVIaLqAztDWEYs1EhTGFfU-ASN51PdGGXhXvT3vHGO7mfKwabGrzQdqbMCclJKsFrkUG3_4HHsMcfb5NkfzAuqaYZghOUBtDStH0aox20PFBAVaLOQqDWt_-UCCyVIs5eebNefG8H0z3OHF2I_ffnfs6tdr1UfvWpkeMAK6wgIyxE3YfXP54-uXmexPVwWg3HdRiMq0wL0FKAZBluZQk_QerU6YU</recordid><startdate>199711</startdate><enddate>199711</enddate><creator>Fournier, Natalie</creator><creator>Paul, Jean-Louis</creator><creator>Atger, Veronique</creator><creator>Cogny, Anne</creator><creator>Soni, Theophile</creator><creator>de la Llera-Moya, Margarita</creator><creator>Rothblat, George</creator><creator>Moatti, Nicole</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>199711</creationdate><title>HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum</title><author>Fournier, Natalie ; Paul, Jean-Louis ; Atger, Veronique ; Cogny, Anne ; Soni, Theophile ; de la Llera-Moya, Margarita ; Rothblat, George ; Moatti, Nicole</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5419-8337ca133877b5a5d6b18ed84fe3499e571de3ce230a4760031bf21295ddf2ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Apolipoproteins - blood</topic><topic>Biological and medical sciences</topic><topic>Cholesterol - metabolism</topic><topic>Cholesterol, HDL - analysis</topic><topic>Disorders of blood lipids. Hyperlipoproteinemia</topic><topic>Humans</topic><topic>Hypercholesterolemia - blood</topic><topic>Lipoproteins, HDL - blood</topic><topic>Liver - metabolism</topic><topic>Liver Neoplasms, Experimental - metabolism</topic><topic>Liver Neoplasms, Experimental - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Phosphatidylethanolamines - blood</topic><topic>Phospholipids - blood</topic><topic>Rats</topic><topic>Sphingomyelins - blood</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fournier, Natalie</creatorcontrib><creatorcontrib>Paul, Jean-Louis</creatorcontrib><creatorcontrib>Atger, Veronique</creatorcontrib><creatorcontrib>Cogny, Anne</creatorcontrib><creatorcontrib>Soni, Theophile</creatorcontrib><creatorcontrib>de la Llera-Moya, Margarita</creatorcontrib><creatorcontrib>Rothblat, George</creatorcontrib><creatorcontrib>Moatti, Nicole</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fournier, Natalie</au><au>Paul, Jean-Louis</au><au>Atger, Veronique</au><au>Cogny, Anne</au><au>Soni, Theophile</au><au>de la Llera-Moya, Margarita</au><au>Rothblat, George</au><au>Moatti, Nicole</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>1997-11</date><risdate>1997</risdate><volume>17</volume><issue>11</issue><spage>2685</spage><epage>2691</epage><pages>2685-2691</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><coden>ATVBFA</coden><abstract>The relationships of cell cholesterol efflux to HDL phospholipid (PL) content and composition in human serum were analyzed in two groups of subjects selected on the basis of their HDL cholesterol (HDL-C) levelsa norm-HDL group (1.10 mmol/L < HDL-C < 1.50 mmol/L) and a high-HDL group (HDL-C > 1.75 mmol/L). In the high-HDL group, the relative fractional efflux was significantly higher than in the norm-HDL group, and in both groups, fractional efflux was correlated with a number of lipoprotein parameters, the best correlation and the only one that remained significant after multivariate analysis being with HDL phospholipid (HDL-PL). Analysis of the HDL-PL subclasses revealed that HDL in the high-HDL sera was enriched with phosphatidylethanolamine (HDL-PE) and relatively deficient in sphingomyelin (HDL-SM) compared with norm-HDL sera. Moreover, the fractional efflux values in the high-HDL group were negatively correlated with the proportion of HDL-PE (r = -.64, P < .0001) and positively correlated with the proportion of HDL-SM (r = .43, P < .01). Thus, this study provides evidence that HDL-PL concentration can he used to predict the capacity of serum to accept cellular cholesterol. Among the differences described between norm-HDL and high-HDL sera, the variability in PE to SM ratio might reflect changes in serum cholesterol acceptors that modulate the first step of reverse cholesterol transport. (Arterioscler Thromb Vasc Biol. 1997;17:2685-2691.)</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>9409243</pmid><doi>10.1161/01.atv.17.11.2685</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1079-5642 |
ispartof | Arteriosclerosis, thrombosis, and vascular biology, 1997-11, Vol.17 (11), p.2685-2691 |
issn | 1079-5642 1524-4636 |
language | eng |
recordid | cdi_proquest_miscellaneous_79487087 |
source | MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection |
subjects | Animals Apolipoproteins - blood Biological and medical sciences Cholesterol - metabolism Cholesterol, HDL - analysis Disorders of blood lipids. Hyperlipoproteinemia Humans Hypercholesterolemia - blood Lipoproteins, HDL - blood Liver - metabolism Liver Neoplasms, Experimental - metabolism Liver Neoplasms, Experimental - pathology Male Medical sciences Metabolic diseases Phosphatidylethanolamines - blood Phospholipids - blood Rats Sphingomyelins - blood Tumor Cells, Cultured |
title | HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T08%3A21%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HDL%20Phospholipid%20Content%20and%20Composition%20as%20a%20Major%20Factor%20Determining%20Cholesterol%20Efflux%20Capacity%20From%20Fu5AH%20Cells%20to%20Human%20Serum&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Fournier,%20Natalie&rft.date=1997-11&rft.volume=17&rft.issue=11&rft.spage=2685&rft.epage=2691&rft.pages=2685-2691&rft.issn=1079-5642&rft.eissn=1524-4636&rft.coden=ATVBFA&rft_id=info:doi/10.1161/01.atv.17.11.2685&rft_dat=%3Cproquest_cross%3E25294228%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204288303&rft_id=info:pmid/9409243&rfr_iscdi=true |